Medicine & Life Sciences
High-Intensity Interval Training
100%
timolumab
87%
Sclerosing Cholangitis
44%
Resistance Training
39%
Overweight
31%
Leg
27%
Muscles
26%
Type 2 Diabetes Mellitus
26%
Cell Count
26%
Monoclonal Antibodies
25%
Blood Vessels
20%
Quadriceps Muscle
17%
Alkaline Phosphatase
15%
Proteins
12%
Liver Diseases
11%
Wounds and Injuries
10%
Serum
9%
Obesity
9%
Amines
9%
National Institutes of Health (U.S.)
9%
Liver
9%
Sarcopenia
8%
Liver Cirrhosis
8%
Oxidoreductases
8%
Safety
7%
Disease Progression
7%
Fluorescence Microscopy
6%
Medical Futility
6%
Calorimetry
6%
Cardiorespiratory Fitness
5%
Phase II Clinical Trials
5%
Muscle Development
5%
Intention to Treat Analysis
5%
Financial Management
5%
Social Sciences
chronic illness
34%
endurance
6%